Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
-
Hydrofarm Holdings Group to Participate in the 2024 ICR Conference
-
Umoja Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
EmployNext Expands Reach to Kitchener-Waterloo-Barrie Areas, Delivering Exceptional Employment Services to a Wider Community
-
Sono-Tek Completes Senior Management Transition
-
Accolade To Present at Upcoming Investor Conferences
-
Freshpet, Inc. to Participate in the 2024 ICR Conference
-
CymaBay Therapeutics to Present at the 42nd Annual JP Morgan Healthcare Conference 2024
-
Jasper Therapeutics, Inc. Announces Reverse Stock Split
-
Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients
-
Asia Pacific Wire & Cable Corporation Limited Reports Third Quarter 2023 Financial Results
-
NANO Nuclear Energy to Present and Named as Groundbreaker Sponsor at the Upcoming POWERGEN International 2024 Conference Held on Jan. 23-25, 2024 in New Orleans
-
Vislink Appoints Industry Veteran Bill Sweeney as New Managing Director of MilGov Business Segment
-
RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Court Finds Corcept Therapeutics’ Patents Not Infringed
-
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
-
Anavex Life Sciences Provides an Update on Rett Syndrome Program
-
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
-
Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
-
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Sterling to Offer Market Leading Clinical Solutions Through Acquisition of Vault Workforce Screening
-
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Platform Presentation at the 20th Annual WORLDSymposium™ 2024
-
Perspective Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Provident Financial Services, Inc. Schedules Fourth Quarter and Year-End Earnings Conference Call
-
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
-
Healis Therapeutics Announces Supply Agreement with CKD Bio to develop CKDB-501 for neuropsychiatric indications
-
Misericordia University Faculty Book Published by the University of Pennsylvania Press
-
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
-
H World Group Limited Announces the Change of Officers
-
Kadant Completes Acquisition of Key Knife, Inc.
-
Branded Legacy, Inc. ($BLEG) Retires Additional 442 Million Common Shares, Surpassing Initial Commitment
-
Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Department of Defense Awards TranzactCard With Patriotic Employer Award
-
Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024
-
Watsco Declares $2.45 Quarterly Dividend and Commemorates Paying Dividends for 50 Consecutive Years
-
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
-
XOMA Announces Stock Repurchase Program of up to $50 Million
-
Streamline Health® Expands Agreement With Existing eValuator™ Client to Add RevID™
-
AppTech Successfully Boards its First International Airport Onto its Newly Acquired FinZeo Platform for Payment Processing
-
UPM finalized the sale of its Steyrermühl site to HEINZEL GROUP
-
DSM: Net Asset Value(s) and Portfolio
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
ProVen Growth and Income VCT plc: Total voting rights
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 29 12 2023] - (CGWL)
-
ProVen VCT plc: Total voting rights
-
Net Asset Value(s)
-
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
-
Director/PDMR Shareholding
